Angiotensin AT2 receptor protects against cerebral ischemia‐induced neuronal injury
- 21 January 2005
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 19 (6) , 1-25
- https://doi.org/10.1096/fj.04-2960fje
Abstract
Several lines of clinical and experimental evidence suggest an important role of the renin-angiotensin system in ischemic brain injury although the cellular regulation of the angiotensin AT1 and AT2 receptors and their potential relevance in this condition have not yet been clearly defined. We first assessed the regulation of brain AT1 and AT2 receptors in response to transient unilateral medial cerebral artery occlusion in rats by real-time RT-PCR, Western blot, and immunofluorescence labeling. AT2 receptors in the peri-infarct zone were significantly upregulated 2 days after transient focal cerebral ischemia. Increased AT2 receptors, which were abundantly distributed in a large number of brain regions adjacent to the infarct area including cerebral frontal cortex, piriform cortex, striatum, and hippocampus, were exclusively expressed in neurons. By contrast, AT1 receptors, which remained unaltered, were mainly expressed in astrocytes. In neurons of ischemic striatum, increased AT2 receptors were associated with intense neurite outgrowth. Blockade of central AT2 receptors with PD123177 abolished the neuroprotective effects of central AT1 receptor blockade with irbesartan on infarct size and neurological outcome. In primary cortical neurons, stimulation of AT2 receptors supported neuronal survival and neurite outgrowth. Our data indicate that cerebral AT2 receptors exert neuroprotective actions in response to ischemia-induced neuronal injury, possibly by supporting neuronal survival and neurite outgrowth in peri-ischemic brain areas.Keywords
This publication has 41 references indexed in Scilit:
- Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in ratsJournal Of Hypertension, 2003
- Protection Against Ischemia and Improvement of Cerebral Blood Flow in Genetically Hypertensive Rats by Chronic Pretreatment With an Angiotensin II AT 1 AntagonistStroke, 2002
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololPublished by Elsevier ,2002
- Review: The renin-angiotensin system in the brain: an updateJournal of the Renin-Angiotensin-Aldosterone System, 2001
- Angiotensin II AT 1 Blockade Normalizes Cerebrovascular Autoregulation and Reduces Cerebral Ischemia in Spontaneously Hypertensive RatsStroke, 2000
- Blockade of Central Angiotensin AT 1 Receptors Improves Neurological Outcome and Reduces Expression of AP-1 Transcription Factors After Focal Brain Ischemia in RatsStroke, 1999
- Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trialThe Lancet, 1999
- Protective Effects of Candesartan Cilexetil (TCV-116) Against Stroke, Kidney Dysfunction and Cardiac Hypertrophy in Stroke-Prone Spontaneously Hypertensive RatsClinical and Experimental Hypertension, 1997
- Differences in Mortality Rate between Abrupt and Progressive Carotid Ligation in the Gerbil: Role of Endogenous Angiotensin IIJournal of Cerebral Blood Flow & Metabolism, 1988
- Angiotensin II decreases mortality rate in gerbils with unilateral carotid ligation.Stroke, 1986